NG
REGN icon

Norden Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Norden Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.25M Buy
1,622
+163
+11% +$125K 0.12% 159
2025
Q4 		$1.13M Buy
1,459
+353
+32% +$240K 0.11% 168
2025
Q3 		$622K Buy
1,106
+563
+104% +$318K 0.06% 291
2025
Q2 		$285K Sell
543
-38
-7% -$21.2K 0.03% 456
2025
Q1 		$368K Buy
581
+81
+16% +$55.7K 0.04% 378
2024
Q4 		$356K Sell
500
-159
-24% -$133K 0.04% 381
2024
Q3 		$693K Buy
659
+244
+59% +$272K 0.08% 265
2024
Q2 		$436K Buy
415
+27
+7% +$26.2K 0.09% 239
2024
Q1 		$373K Buy
388
+126
+48% +$120K 0.08% 289
2023
Q4 		$230K Buy
+262
New +$216K 0.04% 241

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Norden Group's REGN Position: Q1 2026 in Review

Norden Group increased its Regeneron Pharmaceuticals (REGN) stake by 11% in Q1 2026, buying an estimated $125K and bringing the position to 1,622 shares worth $1.25M. The position accounts for 0.12% of the portfolio, ranked #159.

Norden Group first reported a position in REGN in Q4 2023 and has held it in 10 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Norden Group held 1,622 shares of Regeneron Pharmaceuticals worth $1.25M as of Q1 2026.
  • Norden Group bought 163 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $125K.
  • Regeneron Pharmaceuticals made up 0.12% of Norden Group's portfolio in Q1 2026, its #159 holding.
  • Norden Group first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Norden Group's 13F filing for Q1 2026, filed 15 Apr 2026.